15.81 +0.18 (1.14%)
SMTS
Stock Details
Last Trade:15.81 Change:+0.18 (1.14%) Prev Close:15.63 Open: 15.83 Days Range:15.60 – 15.92 52 Week Range: 10.18 - 18.70 Volume:75115 P/E: 29.83EPS:0.53
View AllRecent Alerts 02/09/10
Recent Alert on 01/21/10 at 8:28am
Somanetics (SMTS) Posts Q4 EPS of $0.22, Beats by 3c; Sees FY10 Revs Below Street
Somanetics (SMTS) Posts Q4 EPS of $0.22, Beats by 3c; Sees FY10 Revs Below Street
Somanetics Corporation (NASDAQ: SMTS) reports Q4 EPS of $0.22, 3 cents better than the analyst estimate of $0.19. Revenue for the quarter was $14.5 million, which compares to the estimate of $14.76 million. Sees FY10 revs of $56 million, versus... Read More
Recent Alert on 01/21/10 at 8:28am
Somanetics (SMTS) Posts Q4 EPS of $0.22, Beats by 3c; Sees FY10 Revs Below Street
Somanetics (SMTS) Posts Q4 EPS of $0.22, Beats by 3c; Sees FY10 Revs Below Street
Recent Alert on 01/20/10 at 3:27pm
Trading Radar for 1/21: Google (GOOG), Goldman Sachs (GS), Western Digital (WDC), Intuitive Surgical (ISRG) Report
Trading Radar for 1/21: Google (GOOG), Goldman Sachs (GS), Western Digital (WDC), Intuitive Surgical (ISRG) Report
Recent Alert on 12/11/09 at 3:01pm
Trading Radar for 12/14: Somanetics (SMTS), Take-Two Interactive (TTWO), Alico (ALCO) Report
Trading Radar for 12/14: Somanetics (SMTS), Take-Two Interactive (TTWO), Alico (ALCO) Report
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/08/10 at 3:35pm
Form SC 13D/A SOMANETICS CORP Filed by: DISCOVERY EQUITY PARTNERS, LP
Form SC 13D/A SOMANETICS CORP Filed by: DISCOVERY EQUITY PARTNERS, LP
View AllRecent Blog Posts
Blog Posts on 10/14/09 at 12:09pm
BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics
BioMed News Bytes: Progenics, Somanetics, Ziopharm, Cardium, pSivida, BioMimetic Therapeutics
Blog Posts on 10/11/09 at 3:15am
M&A Watch: 8 Medical Consumables Companies That Look Like Buyout Targets
M&A Watch: 8 Medical Consumables Companies That Look Like Buyout Targets

